Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206062 · ClinicalTrials.gov registry record · NA
Systolic Blood Pressure Intervention Trial
A NA study of Hypertension, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
- 9,361
- Enrollment target
- 1
- Study location
NCT01206062: Completed NA study of Hypertension, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT01206062 is a NA study of Hypertension that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 9,361 participants, above the 3,487-participant average among 470 other Hypertension trials with a reported enrollment target (168% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01206062, a NA study of Hypertension, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
- 9,361 participants
- Enrollment target
- 1
- Study location
Study Summary
Elevated blood pressure (BP) is an important public health concern. It is highly prevalent, the prevalence may be increasing, and it is a risk factor for several adverse health outcomes, especially coronary heart disease, stroke, heart failure, chronic kidney disease, and decline in cognitive function. The Systolic Blood Pressure Intervention Trial (SPRINT) is a 2-arm, multicenter, randomized clinical trial designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal than currently recommended will reduce cardiovascular disease (CVD) risk.
Conditions Studied
Interventions
- DRUG Intensive control of SBP
- DRUG Standard control of SBP
Study Locations (1)
North Carolina
- Wake Forest University School of Medicine - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,361 participants |
| Start Date | 2010-10 |
| Est. Completion | 2019-03 |
| Phase | NA |
What the finished NCT01206062 record still lists
NCT01206062 is an interventional study that assigns participants to a tested intervention. Its 9,361 participants enrollment target places it among the larger protocols in the corpus, above the 3,487-participant average among 470 other Hypertension trials with a reported enrollment target (168% higher).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Intensive control of SBP is the first listed.
NCT01206062 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01206062 about?
NCT01206062 is a clinical study titled "Systolic Blood Pressure Intervention Trial". Elevated blood pressure (BP) is an important public health concern. It is highly prevalent, the prevalence may be increasing, and it is a risk factor for several adverse health outcomes, especially coronary heart disease, stroke, heart failure, chronic kidney disease, and decline in cognitive functi...
What is the current status of trial NCT01206062?
This trial is currently completed. It is a NA study. The enrollment target is 9,361 participants. The study started on 2010-10. Estimated completion is 2019-03.
What conditions does trial NCT01206062 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT01206062?
The interventions under investigation include: Intensive control of SBP (DRUG), Standard control of SBP (DRUG).
Who is sponsoring clinical trial NCT01206062?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01206062 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01206062's enrollment target sits among peer trials
9,361 23rd of 470 higher than 448 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia